Infection
A select series of steps guides hepatitis B virus entry into cells
Published in Hepatitis Weekly, September 27th, 2004
"Little is known about cellular determinants essential for human hepatitis B virus infection. Using the duck hepatitis B virus as a model, we first established a sensitive binding assay for both virions and subviral particles and subsequently elucidated the characteristics of the early viral entry steps," scientists in Germany report.
"The infection itinerary was found to initiate with the attachment of viral particles to a low number of binding sites on hepatocytes (about 104 per cell)," said A. Funk and colleagues, Heinrich Pette Institute of Experimental Virology and Immunology,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-09-27)
More Articles from Hepatitis Weekly
- Chronic Liver Disease
Silent hepatitis B does not alter hepatitis C-related liver disease - Environmental Health
Combined technologies detect hepatitis A virus in environmental samples - Immunology
Fine-needle aspiration biopsies predict how hepatitis C will respond to therapy - Liver Fibrosis
Hepatitis B virus X antigen activates fibrinogen gene expression - Recombinant Research
Lymphoblastoid interferon may clear hepatitis B better than recombinant therapy - Antiviral Therapy
Chronic hepatitis C nonresponders are a challenge to clinical management - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
